HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.

AbstractBACKGROUND:
Neuroendocrine (NE) differentiation in prostate cancer has been correlated with a poor prognosis and hormone refractory disease. In a previous report, we demonstrated the presence of immunoreactive cytoplasmic hypoxia inducible factor 1alpha (HIF1alpha), in both benign and malignant NE prostate cells. HIF1alpha and HIF1beta are two subunits of HIF1, a transcription factor important for angiogenesis. The aim of this study was to elucidate whether the cytoplasmic stabilization of HIF1alpha in androgen independent NE differentiated prostate cancer is due to the presence of certain HIF1alpha isoforms.
METHODS:
We studied the HIF1alpha isoforms present in 8 cases of benign prostate hyperplasia (BPH) and 43 cases of prostate cancer with and without NE differentiation using RT-PCR, sequencing analysis, immunohistochemistry and in situ hybridization.
RESULTS:
We identified multiple isoforms in both benign and malignant prostate tissues. One of these isoforms, HIF1alpha1.2, which was previously reported to be testis specific, was found in 86% of NE-differentiated prostate tumors, 92% of HIF1alpha immunoreactive prostate tumors and 100% of cases of benign prostate hyperplasia. Immunohistochemistry and in situ hybridization results showed that this isoform corresponds to the cytoplasmic HIF1alpha present in androgen-independent NE cells of benign and malignant prostate tissue and co-localizes with immunoreactive cytoplasmic HIF1beta.
CONCLUSION:
Our results indicate that the cytoplasmic stabilization of HIF1alpha in NE-differentiated cells in benign and malignant prostate tissue is due to presence of an HIF1alpha isoform, HIF1alpha1.2. Co-localization of this isoform with HIF1beta indicates that the HIF1alpha1.2 isoform might sequester HIF1beta in the cytoplasm.
AuthorsNastaran Monsef, Maria Soller, Ioannis Panagopoulos, Per Anders Abrahamsson
JournalBMC cancer (BMC Cancer) Vol. 10 Pg. 385 (Jul 21 2010) ISSN: 1471-2407 [Electronic] England
PMID20663134 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Protein Isoforms
  • RNA, Messenger
Topics
  • Adenocarcinoma (genetics, metabolism, pathology)
  • Aged
  • Cell Differentiation
  • Cell Nucleus (metabolism)
  • Cytoplasm (metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Immunoenzyme Techniques
  • In Situ Hybridization
  • Male
  • Neoplasms, Hormone-Dependent (genetics, metabolism, pathology)
  • Neurosecretory Systems (pathology)
  • Prognosis
  • Prostate (metabolism, pathology)
  • Prostatic Hyperplasia (genetics, metabolism, pathology)
  • Prostatic Neoplasms (genetics, metabolism, pathology)
  • Protein Isoforms
  • RNA, Messenger (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: